The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / According to MRI, Ultrasound Guidance Does Not Improve Treat-to-Target in RA

According to MRI, Ultrasound Guidance Does Not Improve Treat-to-Target in RA

February 5, 2020 • By Reuters Staff

  • Tweet
  • Email
Print-Friendly Version / Save PDF

NEW YORK (Reuters Health)—Ultrasound guidance does not improve the effectiveness of treat-to-target therapy in rheumatoid arthritis (RA), new findings confirm.

You Might Also Like
  • MRI-Guided Therapy Offers No Improvement Over Conventional Treat to Target for RA
  • Ultrasound as RA Treat-to-Target Strategy Doesn’t Improve Long-Term Outcomes
  • Predictive Value of Whole-Body MRI & Ultrasound Explored in EULAR Studies

“Incorporating ultrasound information in treatment decisions did not lead to reduced MRI inflammation or less structural damage compared with a conventional treatment strategy,” Dr. Ulf Sundin of Diakonhjemmet Hospital, Oslo, and colleagues write in Rheumatology. “The findings support that systematic use of ultrasound does not provide a benefit in the follow-up of patients with early RA.”1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The goal of RA care today is to treat patients to clinical remission, but these patients may still have subclinical inflammation visible on ultrasound or magnetic resonance imaging, Dr. Sundin and his team note. Two trials of structured ultrasound assessment in patients with early RA did not show a benefit of targeting imaging remission instead of clinical remission, they add, although there was a trend toward the ultrasound groups in both studies showing less radiographic erosive damage.

In the current study, the authors analyzed data from one of these trials, the ARCTIC trial, on 218 participants who had magnetic resonance imaging (MRI) scans at baseline and at least one follow-up MRI.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

There were no differences between the ultrasound group and the conventional treat-to-target group in bone marrow edema, synovitis or tenosynovitis based on MRI, which improved for the first year of the study with sustained benefit over the second year. The risk of progression to erosions on MRI was also similar for both groups, at 39% with ultrasound and 33% without ultrasound (P=0.40).

“The MRI results, with no trend towards less joint damage progression in the ultrasound arm, support the conclusions of the primary outcomes of the above mentioned trials—that an ultrasound-guided strategy does not lead to improved treatment outcomes,” Dr. Sundin and colleagues write.

“Our findings support the current treatment recommendations for early RA,” they conclude.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Reference

  1. Sundin U, Aga AB, Skare Ø, et al. Conventional versus ultrasound treat to target: No difference in magnetic resonance imaging inflammation or joint damage over 2 years in early rheumatoid arthritis. Rheumatology (Oxford). 2020 Jan 30. pii: kez674. [Epub ahead of print]

Filed Under: Conditions, Rheumatoid Arthritis Tagged With: imaging, Magnetic resonance imaging (MRI), MRI, Rheumatoid Arthritis (RA), Treat-to-Target, Ultrasound

You Might Also Like:
  • MRI-Guided Therapy Offers No Improvement Over Conventional Treat to Target for RA
  • Ultrasound as RA Treat-to-Target Strategy Doesn’t Improve Long-Term Outcomes
  • Predictive Value of Whole-Body MRI & Ultrasound Explored in EULAR Studies
  • Whole-Body MRI, Ultrasound Imaging May Aid in Early Rheumatic Disease Diagnosis, Treatment

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)